Regenacy Pharmaceuticals LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.regenacy.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy
Phase 2
Completed
- Conditions
- Painful Diabetic Peripheral Neuropathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-06-05
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Regenacy Pharmaceuticals LLC
- Target Recruit Count
- 282
- Registration Number
- NCT03176472
- Locations
- 🇺🇸
Pinnacle Research Group LLC, Anniston, Alabama, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Diabetes/Lipid Management & Research Center, Huntington Beach, California, United States
News
No news found